Cite
MiR‐330‐3p contributes to INS‐1 cell dysfunction by targeting glucokinase in gestational diabetes mellitus.
MLA
Xiao, Yuping, et al. “MiR‐330‐3p Contributes to INS‐1 Cell Dysfunction by Targeting Glucokinase in Gestational Diabetes Mellitus.” Journal of Obstetrics & Gynaecology Research, vol. 46, no. 6, June 2020, pp. 864–75. EBSCOhost, https://doi.org/10.1111/jog.14249.
APA
Xiao, Y., Ding, J., Shi, Y., Lin, L., Huang, W., Shen, D., & Wang, W. (2020). MiR‐330‐3p contributes to INS‐1 cell dysfunction by targeting glucokinase in gestational diabetes mellitus. Journal of Obstetrics & Gynaecology Research, 46(6), 864–875. https://doi.org/10.1111/jog.14249
Chicago
Xiao, Yuping, Jingchao Ding, Yulan Shi, Long Lin, Wenyuan Huang, Dongxia Shen, and Weiqun Wang. 2020. “MiR‐330‐3p Contributes to INS‐1 Cell Dysfunction by Targeting Glucokinase in Gestational Diabetes Mellitus.” Journal of Obstetrics & Gynaecology Research 46 (6): 864–75. doi:10.1111/jog.14249.